Northwest Investment Counselors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $23.3K | Buy |
+570
| New | +$23.3K | 0.01% | 331 |
|
2024
Q2 | – | Sell |
-400
| Closed | -$17.1K | – | 291 |
|
2024
Q1 | $17.1K | Buy |
+400
| New | +$17.1K | ﹤0.01% | 331 |
|
2023
Q4 | – | Sell |
-420
| Closed | -$15.2K | – | 296 |
|
2023
Q3 | $15.2K | Buy |
420
+20
| +5% | +$725 | ﹤0.01% | 341 |
|
2023
Q2 | $14.3K | Sell |
400
-377
| -49% | -$13.4K | ﹤0.01% | 349 |
|
2023
Q1 | $27.6K | Hold |
777
| – | – | 0.01% | 296 |
|
2022
Q4 | $27.3K | Buy |
777
+600
| +339% | +$21.1K | 0.01% | 301 |
|
2022
Q3 | $5K | Sell |
177
-1
| -0.6% | -$28 | ﹤0.01% | 427 |
|
2022
Q2 | $10K | Buy |
+178
| New | +$10K | ﹤0.01% | 356 |
|
2020
Q4 | – | Sell |
-433
| Closed | -$20K | – | 263 |
|
2020
Q3 | $20K | Buy |
+433
| New | +$20K | 0.01% | 266 |
|
2019
Q4 | – | Sell |
-433
| Closed | -$23K | – | 294 |
|
2019
Q3 | $23K | Buy |
+433
| New | +$23K | 0.01% | 277 |
|
2017
Q4 | – | Sell |
-909
| Closed | -$46K | – | 205 |
|
2017
Q3 | $46K | Buy |
+909
| New | +$46K | 0.02% | 185 |
|